Loading…

EE668 Empagliflozin for the Treatment of Adult Patients With Symptomatic Chronic Heart Failure With Reduced Ejection Fraction (HFREF): A Cost-Effectiveness Analysis From the Italian NHS Perspective

Saved in:
Bibliographic Details
Published in:Value in health 2022-12, Vol.25 (12), p.S188-S188
Main Authors: Colombo, GL, Di Matteo, S, Bruno, G, Martinotti, C, Linden, S
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2022.09.907